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Abstract
Motivated by several recent experimental observations that vitamin-D could interact with antigen 
presenting cells (APCs) and T-lymphocyte cells (T-cells) to promote and to regulate different stages 
of immune response, we developed a coarse grained kinetic model in an attempt to quantify the role  
of vitamin-D in immunomodulatory responses.  Our kinetic model,  developed using the ideas of 
chemical network theory, leads to a system of nine coupled equations that we solve both by direct 
and by stochastic (Gillespie) methods. Both the analyses consistently provide detail information on 
the dependence of  immune response  to the variation of  critical  rate  parameters.  We find that 
although vitamin-D plays a negligible role in the initial  immune response,  it  exerts a profound 
influence in the long term, especially in helping the system to achieve a new, stable steady state. The 
study explores the role of vitamin-D in preserving an observed bistability in the phase diagram 
(spanned by system parameters) of immune regulation, thus allowing the response to tolerate a 
wide range of pathogenic stimulation which could help in resisting autoimmune diseases. We also 
study how vitamin-D affects the time dependent population of dendritic cells that connect between 
innate  and  adaptive  immune  responses.  Variations  in  dose  dependent  response  in  anti-
inflammatory and pro-inflammatory T-cell  populations  to  vitamin-D correlate  well  with recent 
experimental results.  Our kinetic model allows for an estimation of the range of optimum level of 
vitamin-D required for smooth functioning of the immune system and for control of both hyper-
regulation and inflammation. Most importantly, the present study reveals that an overdose or toxic 
level of vitamin-D or any steroid analogue could give rise to too large a tolerant response, leading to 
an inefficacy in adaptive immune function.
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Introduction
 It is now certain that vitamin-D is involved in large number distinct immune responses, 
although our quantitative understanding of these processes at cellular level still remains largely 
incomplete.  This  is  because  of  the  enormous  complexity  of  human  immune  system  which 
depends  on  a  large  number  of  interacting  (some  may  be  still  unknown)  components. 
Furthermore, the immune system is not only time dependent but also individual case specific. 
Spurred by modern epidemiologic studies, efforts in the last two decades have been directed 
towards understanding the origin of non-classical immunomodulatory responses believed to be 
triggered by active 1, 25-dihydroxy vitamin-D [1-6]. Beyond its established classical function in 
calcium metabolism,  studies  on  vitamin-D are  now progressively  focused  on  its  pleiotropic 
actions [1-6].
Vitamin-D mediated infection remedial therapies have been followed over past 150 years. 
Since early 1900s, usage of cod-liver oil and UV light became widely recognized as the essential  
sources of vitamin-D. Therapeutic use of vitamin-D first drew attention in 1849, when William 
used cord- liver oil to cure over 400 tuberculosis (TB) patients [7]. After a long 50 years gap, 
Niels Finsen won the Nobel prize by highlighting the medicinal approach of UV exposure by 
which he treated over 800 patients affected by lupus vulgaris (a cutaneous form of TB) [8, 9].  In 
Indian traditional Auyrvedic treatments, use of sunlight to treat and reduce diseases goes back to 
several thousand years where it is referred to as “Suryavigyan” (Meaning: science of Sun light).
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Vitamin-D  plays  distinct  roles  both  in  innate  and  adaptive  immunity.  Several 
experimental and clinical studies have revealed that endogenously produced active vitamin-D (1, 
25(OH)2D3)  in  macrophages  enhances  the  production  rate  of  anti-microbial  peptides 
(cathelicidin,  β-defensins,  etc),  to  promote  the innate  immunity  [10,  11].   Subsequently,  the 
conversion of 25-D3 into functional 1, 25-D3 (known as active vitamin-D and referred to as D*) 
in antigen presenting cells (APCs, such as dendritic cells, macrophages) exerts potent effect on 
adaptive immune system [12]. Past epidemiologic data highlight  the link between vitamin-D 
insufficiency and a range of immune-mediated disorders namely various types of autoimmune 
diseases.  Experimental  studies  on  the  immunomodulatory  properties  of  vitamin-D show that 
autoimmunity is primarily driven by enhanced number of T helper cells (e.g. Th1) that attack 
various self-tissues in the body. In particular, the inhibitory effect of vitamin-D on such pro-
inflammatory T-cell responses and promoting regulatory T-cells (TReg), may, at least in part, have 
begun to explain some of these associations [11-15]. 
Some recent  experimental  studies  shed light  on such regulatory  actions  exerted  by both 
vitamin-D and regulatory T-cells and their interplay in resisting autoimmunity.  However, the 
distinct functionalities of the effector T-cells (briefly defined in the supplementary material: S1) 
[16] often found to evolve in presence of antigen arrested by antigen presenting cells (APCs) that 
impel the appropriate co-stimulatory signals to induce mature native T-cells [17, 18].  In the year 
of  2000,  Jonuleit  and  coworkers  characterized  different  types  of  T  cell  responses  that  are 
crucially dependent on maturation phase of the dendritic cells (DCs). They reported that while 
stimulation by mature DCs results in a strong expansion of inflammatory Th1 cells, contacts of 
the  native  T-cells  with  immature  DCs promote  the  development  of  IL-10,  producing T cell 
regulatory 1-like cells  [19].   In 2003, Powrie and Maloy proposed an interaction scheme by 
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surveying such inter relation between APCs and T-cell responses [20].  During the same period 
of time, Piemonti and coworker mentioned about the distinct role of 1,25(OH)2D3 in modulating 
the immune responses through the inhibition of DC differentiation and maturation into potent 
APCs [21].  The role of vitamin-D has also emerged into the fact that while the active form of 
vitamin-D adversely affects  T cell  activation,  proliferation and differentiation,  it  additionally 
facilitates  the  production  of  regulatory  T  cells  (TReg)  that  functions  as  an  effective  immune 
controller [22-24].  Research on the role of vitamin-D greatly benefitted from the recent study by 
Correale et al. Their experiment showed that effector T cells are able to metabolize 25(OH)D3 
into biologically active 1,25(OH)2D3 in DCs, since these T cells express 1α-hydroxylase enzyme 
that constitutively facilitates this conversion [25].
In  the  present  article  we develop a  theoretical  coarse  grained kinetic  network  model 
based  on  the  above  mentioned  experimental  observations.  Our  main  objective  is  to  explore 
quantitatively  the  dependence  of  immunity  on vitamin-D and investigate  its  possible  role  in 
reducing the risk of auto-immune diseases and cancer. We analyze several immunemodulatory 
issues  that  are  controlled  by  vitamin-D,  including  both  innate  and  adaptive  responses  as 
articulated  in  several  experimental  reports  and  reviews  [11-12,  26].   Although  there  are 
numerous other complex biochemical  reactions involved in the immonological  pathways, we 
have considered only a certain number of them that are the essential  participants of immune 
system and have direct interaction with vitamin-D. 
We also address the concern for optimal range of vitamin-D intake that has been raised by World 
Health  Organization‘s  international  agency  for  research  on  cancer.  Present  study  especially 
suggests  that  inhibitory  action  exerted  by  regulatory  T-cell  induced  by  vitamin-D  and  by 
vitamin-D itself on adaptive response could play an important role in prevention of autoimmune 
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diseases. There do exist several early mathematical models that studied inflammatory roles of 
effector T cells and their regulation by regulatory T-cells.  In recent years Friedman et al. studied 
the effect of T cells on inflammatory Bowel Disease [27].   Pillis and coworkers investigated 
effects of regulatory T-cell on renal cell carcinoma treatment [28].  In another model Villoslada 
et al. observed the dynamic cross regulation of antigen-specific effector and regulatory T cell 
subpopulations  in connection  with microglia  in brain autoimmunity  [29].   Perhaps,  the most 
relevant model for the regulation of T-cell in the immune system was presented by a recent paper 
by  Fouchet et  al  [30].  They identified  the  important  ingredients  of  the  immune  system and 
formulated coupled rate equations for the entire process to show the regulation of effector and 
regulatory T-cells by changing various rate constants. 
While all these models are neat, they did not include the essential effects of vitamin-D [27-30]. 
Several experiments have already shown the importance of vitamin-D in both the innate and 
adaptive immune system. Here we have implanted the nonlinear effect of vitamin-D in basic 
model  of  T-cell  regulation.  The  nonlinear  effect  of  vitamin-D comes  indirectly  through the 
pathogen  after  effector  T-cell  production.  The  production  of  effector  T-cell  signals  again 
initializes  the  activation  of  vitamin  D.  This  model  primarily  seeks  to  understand  adaptive  
response activation and effect of vitamin-D on the tolerance/of regulatory nature of the response. 
Hence we have emphasized the regulatory function of vitamin-D in the adaptive immune system. 
We have assumed that the innate mechanism annihilates pathogens at constant rate by production 
of antimicrobial peptides and this leads to the 1st defense against infectious diseases.
The  important  constituents  of  the  model  considered  here  are  the  following:  (i) 
pathogen/antigen/epitope/self-Antigen, (ii) naive T-cell, (iii) myeloid dendritic dell in the form 
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of professional antigen presenting cells  (APC), both in their  resting and activated forms (iv) 
effector  and  regulatory  T  cells,  (v)  inactive  vitamin-D  (25(OH)D3)  and  active  vitamin-D 
(1,25(OH)2D3).  However the participants,  such as vitamin-D receptor (VDR) and the enzyme 
25(OH)D3-1α-hydroxylase (CYP27B1) that simultaneously function over inactive vitamin-D to 
form activate vitamin-D (1,25(OH)2 D)-VDR protein complex, are considered as implicit factors 
for activation of the required transcriptional motif. 
It is important to emphasize here that we have essentially combined the three important 
experimental observations those include the essential features of the adaptive responses reported 
by (i) Powri and Maloy, [20] (ii) Jorge Correale et al. [25] and (iii) Lorenzo Piemonti et al.  [21]. 
In  Figure 1 we have presented the complex interaction network model that includes various 
components and their inter-relation and regulation involved in the immune system. 
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Figure  1:  A  schematic  representation  of  adaptive  immune  responses  in  terms  of  cellular 
interactions including vitamin-D, based on some experimental results and clinical observations.     
 In the scheme, the primary events are the following: (1)  The main step is  the annihilation of  
pathogen by effector T-cells [TEff]. (2) In presence of pathogen inactive APC becomes stimulated 
after pathogen recognition and form resting APC. (3) Resting APC is activated either by pathogen 
or by the presence of any effector T-cell [19, 20]. (4) Activation of effector T-cells are initiated by 
these active APC. (5) Effector T-cells initiates the formation of active vitamin-D from its inactive 
form [24]. (6) Resting APC and active vitamin-D both can stimulate the production of regulatory T-
cell from its precursor [25]. (7) Enhancement of rate of production of effector T-cells is controlled 
7
by  both  regulatory  T-cells  (TReg)  and  active  vitamin-D  [24]. (8)  In  addition,  vitamin-D  and 
regulatory T-cell up-regulate the formation of more resting APC from active APC [21]. 
The present  approach of network kinetic  model  building bears strong resemblance  to 
similar methods adopted earlier in the study of kinetic proof reading [31, 32] and also in enzyme 
kinetics  [33-35].  In all  these studies,  precise quantitative prediction is hindered by imperfect 
knowledge  about  the  system  parameters;  especially  values  of  rate  constants  are  often  not 
available. This lacuna is indeed a source of serious problem not only in study of kinetic proof 
reading, enzyme kinetics but also, as we find here, in theoretical investigations of immunology. 
Finally, master equations involved in all such problems are solved by employing the method of 
mean  first  passage  time  [32,  36,  37],  Gillespie  algorithm  or  straight  forward  numerical 
integration.  We  adopt  both  the  deterministic  approach  by  solving  differential  equations 
numerically and stochastic simulation by employing Gillespie algorithm [38, 39]. The coarse-
graining of interaction network, elaboration of the reaction scheme and the master equations are 
discussed in the method section. 
The values of parameters involved (rate constants and concentrations) may span a wide 
range, and can vary from case to case. Thus, a study of the response to the variation of the  
important  parameters  has  been carried  out.  Such a  study is  clearly  necessary  in  the  present 
context.
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Results 
Under any sort of pathogenic attack, a healthy immune system always aims at killing 
the foreign antigen by enhancing the proliferation and differentiation rate of effector T-cells. 
However, excess number of certain effector T-cells has the negative effect in such a way that 
these  cells  may  fail  to  distinguish  between  body’s  self  and  foreign  peptides  and  may  start 
destroying self tissues. Such events are often characterized as a weak regulation of our immune 
system. Thus a healthy immune system usually functions within a balanced regulation where the 
concentration of effector T-cells remains within a safe range so that it can effectively overcome 
the pathogenic  stimulation  and also can resist  the  exploding growth of effector  T-cells.  The 
production of effector T-cell again depends on the APC activation process controlled by the two 
rate  parameters:  Rate  of  APC  activation  by  pathogenic  stimulation  (kinp) and  rate  of  APC 
reactivation by effector T cells (krese). Here comes the role of vitamin-D whose optimum level 
effectively maintains a balanced immune regulation. Vitamin-D efficiently promotes regulatory 
T-cells activity. Moreover, vitamin-D itself is assigned to reduce the hyper activity of APCs and 
effector T-cells.
In several other model studies only regulatory T-cells are assumed to maintain such 
regulation  [28-30].   There  are  several  experimental  and  clinical  observations  revealing  the 
important  role  of  vitamin-D  and  its  concentration  dependent  effects  in  immune  regulation. 
However  we  are  not  aware  of  a  single  theoretical  model  study  that  has  been  employed  to 
investigate such interesting role of vitamin-D. 
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Effect of vitamin-D on T-cells population: Transition from weak to strong regulation
The opposing role of regulatory and effector T-cells  in immunological activity,  and 
their respective regulation by vitamin-D often determine the strength of immune-regulation and 
the ultimate fate of a disease. The regulation is determined by the activation of APCs followed 
by the activation of effector T-cells. In the present study we have categorized the regulation into 
three groups based on APC and effector T-cell interaction parameter (krese): (i) Strong regulaion, 
(ii) moderate regulation and (iii) weak regulation. To investigate several vitamin-D associated 
factors  we  have  performed  time  evolution  analysis  of  each  participating  element  after  the 
pathogen attack to study their long time behavior. We have studied all these three regulation 
limits  by  varying  krese both  in  the  absence  and  in  the  presence  of  vitamin-D  at  different 
pathogenic/antigenic stimulation (kinp). 
  Numerical results from solution of our system of equations are shown in Figure 2 as a series of 
curves for all the three regulation limits, both in the presence and absence of vitamin-D. The 
results are quite revealing and we discuss them in more detail below.
  Here we find from Figure 2(a) that in absence of vitamin-D when system falls under a 
strong regulation (krese=10) limit, the presence of standard level of vitamin-D, in comparison, is 
found to preserve that strong regulation efficiently (see  Figure 2(b)). At moderate regulation 
regime, vitamin-D is found to maintain the bistable  region (krese=102) as well  that appears in 
absence of vitamin-D (see Figure 2(c)). In an early study, Fouchet and coworker [30] analyzed 
the  steady  state  values  of  T-cells  in  these  three  regulation  regimes  and  showed  the  same 
interesting phenomena but in absence of vitamin-D. We have also observed such bistable region 
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both in absence and presence of vitamin-D as shown in Figure 2(c) and 2(d) where both strong 
and weak regulation can coexist. When we shift the moderate regulation regime towards weakly 
regulated state (krese=103) in absence of vitamin-D (see Figure 2(e)), standard level of vitamin-D 
is still found to create a moderate regulation over the steady state population of effector T-cell 
(see Figure 2(f)). We observe that at very high krese values or a very high antigenic stimulation 
(kinp) the system is always found to fall in a weakly regulated regime where effector T-cells are 
abundant, even if there presents a standard level of vitamin-D. However vitamin-D assists to 
preserve the required (moderate/bistable) regulation over a long range of krese and indeed exerts a 
control over a wide range of pathogenic strength (kinp). Depending on the intensity of antigenic 
stimulation, system mounts on an effective regulation to control the inflammation. This result 
inevitably suggests the important role of vitamin-D in switching on such required regulation.   
11
Figure 2: Variation in T-cell concentration under weak to strong regulation.
Steady state  concentrations of  effector T-cells  (TEff,  shown in red)  and regulatory T-cells  (TReg, 
shown in green) are plotted against various ranges of pathogenic stimulation  ( )inpk at the three 
different APC mediated effector T-cell regulations ( )resek . We find a stable strongly regulated state 
( 10)resek = both (a) in absence of vitamin-D and (b) in presence of vitamin-D. The strong regulation 
remains strong in presence of vitamin-D. An example of bi-stable state:  2( 10 )resek =  where both 
weakly regulated state (shown in dashed line) and strongly regulated state (shown in solid line) can 
coexist (c) in absence of vitamin-D and (d) in presence of vitamin-D. A stable weakly regulated state  
appears 3( 10 )resek =  (e) in absence of vitamin-D. (f) In presence of vitamin-D, it turns out to be a 
bi-stable state up to certain pathogenic stimulation (kinp) limit. Beyond that limit it falls in a weakly 
regulated regime. In the bi-stable situation there always exists an unstable state. Note that here we  
consider the vitamin-D related rate constants as, 7 3* *10 , 10aD eDk k
− −
= =  and the other rate values 
given in Table 1. Optimal vitamin-D concentration signifies the steady state value of vitamin-D 
(~50nmol/lit). 
Subsequent to the previous results it is worth mentioning here that bistability is a key concept for 
understanding the basic phenomena of cellular functioning [40, 41]. Interestingly, in presence of 
vitamin-D  bistability  is  modified  to  be  more  robust  and  to  tolerate  significant  changes  of 
pathogenic  stimulation.  With  the  classification  of  three  regulation  regions  (weak,  moderate, 
strong)  we  investigated  the  boundaries  in  between  any  two.  As  in  previous  plot  now  we 
simultaneously  vary both the rate  of  pathogenic  stimulation  ( )inpk at  the three different  APC 
mediated effector T-cell regulation ( )resek  (see Figure 3). It is necessary to point out that here the 
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deceased production of active APCs is playing a central role in restraining the area of bistable 
region. In absence of vitamin-D, the inhibitory action of regulatory T-cells on active APC and 
thus the enhanced production of resting APCs are particularly responsible for emergence of such 
bistable region. In presence of vitamin-D, such degradation in active APC population enhances 
due  to  the  combined  effects  of  upregulated  regulatory  T-cells  and  Vitamin-D.  Figure  3(b) 
provides a clear description that in presence of standard (optimum) level of vitamin-D, bistable 
region is expanded towards a larger rate of APC mediated effector T-cell activation. However, it 
is evident from the figure that in presence of vitamin-D a weak regulation is afar to achieve. In 
this case the weakly regulation regime is located towards the larger rate values of effector T-cell 
activation.  The result  signifies the strength of vitamin-D which prevents the immune system 
from the over-explosive limit of effector T-cell activity. 
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Figure 3: Impact of vitamin-D over the phase diagram of immune regulation. 
(a) In absence of vitamin-D the pair of regulation rates, (i) pathogenic stimulation ( )inpk and (ii) the 
resting APC mediated effector T-cell regulation ( )resek are varied to find the boundaries  between 
the two specific regulation regions: Weak and strong. These two regulation regimes are intervened 
by a bistable region where a moderate regulation is operated. (b) The same way in presence of  
vitamin-D the  boundaries  separated  regions  are  alienated.  Note  that  in  presence  of  vitamin-D 
boundaries  are  shifted:  strong  regions  become  broader.  Bistable  regions  become  relatively 
expanded.  Weak  regions  become  considerably  compressed  than  what  happens  in  absence  of 
vitamin-D. The rate constants considered here are similar to Figure 2. 
Time evolution of immunological components
In absence of (or at very low concentration) of Vitamin-D
We observed some interesting results from the study of the time evolution analysis of 
the immunological components in the above mentioned three regulation regions. Here we have 
presented the dynamical changes of elements against time (days) that quantitatively explain some 
attributes of the immune responses both in absence (see Figure 4(a)) and presence of vitamin-D 
(see Figure 4(b)). In Figure 4(a) within few hours we see that there is a sudden increase in the 
amount  of  effector  T-cells  which  reaches  to  a  peak value.  This,  as  said  before,  is  typically 
referred  to  the  onset  of  an  adaptive  response.  This  is  in  common  agreement  with  most 
experimental  results  which  suggests  that  recognition  takes  place  within  few hours  after  the 
pathogenic incursion [42, 43].
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We see in Figure 4 that the pathogenic growth starts dying out at a much faster rate immediately 
after the initiation of effector T-cell production. We now have a huge population of effector T-
cells that have been activated from the naive T-cells after APC activation. The population of 
these  T-cells  remains  considerably  higher  even  after  the  population  of  pathogen  becomes 
significantly less. Such explosion in effector T-cell production thus often causes various kinds of 
autoimmune diseases [13-15, 44].
After the death of incoming pathogen a new steady state is developed at longer time. 
Also, once steady state has been reached after 10-20 days or so, one can notice the steady state 
values  of effector  T cells.  This  is  in  accordance  with the fact  that  these T-cells  are  antigen 
specific cells. Once the pathogen is suppressed, the body creates an immunological memory of 
that specific pathogen, which corresponds to a steady state value of effector T cells. It might 
particularly be useful if the same pathogen strikes again. Then the amount of antigen specific T- 
cells  grows  fast  which  would  lead  to  a  rapid  and  more  effective  suppression  of  targeted 
pathogens [45].
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Figure 4: Time evolution of immune response.
The dynamical variation of pathogens and efffector T-cells are calculated both (a) in absence and 
(b) in presence of optimal level of vitamin-D.  In both cases adaptive response sets in after few 
hours of the pathogenic incursion. Pathogens are destroyed when effector T-cells reaches its peak 
value. Although regulatory T-cells control a little over the huge production of effector T-cells even 
after  the  death  of  pathogen  and  its  large  steady  state  concentration  may  increase  the  risk  of 
autoimmune  diseases.  The  presence  of  active  vitamin-D  subsequently  controls  over  the  large 
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production of effector T-cells.  The steady state concentration of  effector T-cells  now low down 
significantly which may decrease the risk of autoimmune diseases. At the same time, note the re-
entrant possibility of pathogen which up to certain level assists to build an adaptive tolerance of the 
immune  system.  (In  both  cases ,inp resek k are  so  chosen  that  they  remain  in  the  bistable  region 
( 10, 100)inp resek k= = as shown in Figure 3. The other rate constants considered here are similar to 
Figure 2.
In the presence of standard level of Vitamin-D 
Vitamin-D plays  a  crucial  role  on  the  onset  of  adaptive  response.  It  modifies  the 
scenario  as  we have  explained  in  the  last  subsection.  Once  the  T-effector  population  starts 
increasing,  production  of  active  vitamin  D  [D*]  is  upregulated.  This,  in  turn,  upregulates 
regulatory T-cell growth, which along with [D*] regulate the aggressive, inflammatory responses 
exerted  by  T-effector  cells,  restoring  order  to  the  body.  However,  in  this  process,  T-cell 
population relaxes at a much faster rate (see Figure 4(b)). As a result, rate of pathogen killing is 
significantly suppressed. In our model vitamin-D activation starts to grow rapidly within day 1 or 
2. Hence we find that active vitamin-D does not play any substantial role in the very initial stage 
of pathogenic growth or decay. In presence of vitamin-D we observe a re-entrant possibility of 
pathogen which may sustain for long time [12].  
In addition, we have studied pathogen relaxation dynamics at different vitamin-D concentrations. 
We have observed that if there would not be any vitamin-D present in our body, pathogenic 
growth would have been more effectively destroyed by the explosive production of effector T-
cells immediately after recognition. But to compensate the large population of effector T-cells, 
vitamin-D plays a role as negative catalyst in effector T-cells production. As a consequence, in 
presence of vitamin-D pathogen annihilation rate at longer time also become suppressed. Hence, 
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we find from the above analysis that in order to stay away from autoimmune diseases while we 
switch on the action of optimal regulation by active vitamin-D, at the same time our immune 
system becomes bound to tolerate some amount of pathogen. In fact, a healthy immune system is 
always  characterized  by  tolerating  certain  extent  of  pathogenic  stimulation.  The  fact,  that 
vitamin-D has been implicated as an important factor in several different autoimmune diseases 
by preserving bistability, suggests its efficiency in controlling body’s self-tolerance [46-48]. It is 
worth  mentioning  here  that  experimental  observations  related  to  the  adoptive  transfer  of 
tolerance also supports the emergence of such bi-stability where the balanced co-existence of 
strong and weakly regulated immune responses is  preserved in the system [49].  However in 
presence of very high concentration of vitamin-D or any of its steroid analogues which exert 
such an over-strong regulation that pathogenic resistance of immune system is totally failed. As a 
consequence, it induces the risk of pathogenic re-attack.   
Steady state analysis and optimal vitamin-D
One important  detail  that  needs to be considered here is  the emergence of the new 
steady state in presence of vitamin-D with its tightly controlled homeostasis. To understand the 
relevance of vitamin-D in the above response, different initial concentrations of vitamin-D, [Din0] 
were considered. We have thus considered the initial concentrations of vitamin-D from lower to 
higher than the steady state value of vitamin-D, from 10-4 to 104 nmol/lit. The variation of T-cell 
levels  and  pathogen  levels  in  the  newly  established  steady  state  were  obtained  and  these 
concentrations are plotted versus log [Din0] in Figure 5. To measure a safe vitamin-D range we 
need to control the immune-regulation as well as pathogenic resistance as these are intimately 
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connected. It is important to note that we cannot establish such a strong regulation by vitamin-D 
beyond which pathogenic resistance by effector T-cell subtly fails.   
Figure 5: Steady state value analyses as a function of log (initial vitamin-D level). 
(a)  Evaluation  of  steady  state  regulation  in  terms  of  effector  T-cell  and  regulatory  T-cell  
concentration at different initial intake of vitamin-D. At certain range of vitamin-D concentration 
(around the value of vitamin-D concentration above 50 nmol/lit) TEff concentration falls than the 
value  of  TReg to  establish  a  strong  regulation  that  is  necessary  for  prevention  of  autoimmune 
diseases. (b) Steady state evaluation of pathogenic resistance in terms of both pathogen and effector  
T-cell concentration at different initial intake of vitamin-D.  At vitamin-D concentration beyond 50 
nmol/lit when system gears up a more strong regulation, the steady state value of pathogen starts on 
increasing even exceeding the value of TEff  beyond  [Din0] =100nmol/lit. However we indicate (with a 
gray limit bar) the optimal vitamin-D ranges from 50 to 100nmol/lit  where both pathogen and 
effector  T-cell  level  remain  at  reasonably  low  value.  Vitamin-D  level  beyond  100nmol/lit 
corresponds to an alarming concentration compared to the standard vitamin-D limit. 
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The  effects  of  local  conversion  of  inactive  25(OH)D3 to  active  1,25(OH)2D3  by  DCs  on 
subsequent T cell responses were measured by flow cytometry and the results were extensively 
analyzed  by  Jeffery  et  al.  [50].  They  studied  how  this  conversion  can  promote  an  anti-
inflammatory T cell phenotype (such as CTLA-4) and inhibit the inflammatory expression of IL-
17, IFN-γ, and IL-21. The dose dependent variations of such T-cell responses were shown in Fig. 
2.(F) in the referred article [50]. The trend of responsive changes along with the concentration of 
25(OH)D3  matches fairly well with the results depicted in  Figure 5 that we obtain from our 
model  calculation.  Following their  cue,  in the present study we also consider the circulating 
inactive form of vitamin D (25(OH)D3) as an efficient marker of vitamin D status. Our dose 
dependent curves also match with the experimental findings of Correale et al. [25].
For the above data set, we find that the optimal vitamin-D level lies in the 50-100 
nmol/lit  range where both pathogen and effector  T-cell  levels remain at  reasonably low risk 
range. Recently a large number of epidemiological studies and  an U.S. Institute of medicine 
committee  reported  that  a  serum 25-hydroxyvitamin-D level  of  >20  ng/mL  (50  nmol/L)  is 
desirable for bone and overall health [51-53].  Those studies recommend both the upper and the 
lower limits of safe vitamin-D intake. High IgE levels were seen at very low 25-hydroxyvitamin-
D3 (<10 ng/mL or, <25 nmol/L) and at very high 25-hydroxyvitamin-D3 (>135 nmol/L) levels 
[52]. 
   Another important study found that high 25(OH)D3 concentration (greater or =100 nmol/L) 
often leads a statistically  significant  (2-fold) enhancement  of pancreatic  cancer risk [53, 54]. 
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Therefore,  the  present  study  provides  an  estimate  in  the  right  range  of  optimal  vitamin-D 
concentration.  
Sensitivity towards vitamin-D associated parameter set
To investigate both the robustness and the sensitivity of vitamin-D related rate constants, 
it  is  essential  to  scrutinize  their  effects  in  a  wide  ranging  scale.  An  additional  reason  to 
substantiate  the  sensitivity  is  that  these  values  vary  from system to  system (here  person to 
person) and the values can fluctuate even for the same person depending on various conditions. 
Though precise number of the rate constants may vary, the effective trend ought to preserve 
within a certain scale. 
As both the active APC and effector T-cells are modulated by the impact of active vitamin-D we 
have investigated the outcome of different possibilities of the combination of  *aDk  and  *eDk
(defined in  Table 1). From  Figure 5 we learned that to obtain a safe boundary of vitamin-D 
impact  we  need  to  efficiently  check  both  effector  T-cell  concentration  as  well  as  pathogen 
concentration.  Here  we  have  scanned  the  parameter  space  to  distinguish  different  zones 
observing  the  population  of  pathogen  and  effector  T-cells.  However  at  high  vitamin-D 
concentration, pathogen may enhance their growth. Here the parameter space ( )* *log , logaD eDk k  
suggests that pathogenic and effector T-cell profile is less sensitive towards *eDk . It rather shows 
a significant variation with the change of *aDk . This analysis shows two distinct regions: (i) In the 
region of  low vitamin-D impact  ( )8 4* 10 10aDk − −−: we obtain  pathogen defeated  zone  where 
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pathogen  concentration  is  found to  be  negligible  but  at  the  same time here  in  the  range of 
( )8 7* 10 10aDk − −−: we found  a  effector  T-cell  flare-up  zone.  (ii)  In  the  region  of  very  high 
vitamin-D impact  ( )1 2* 10 10aDk − −: we obtain  effector  T-cell  defeated  zone.  Here  we find  a 
pathogen relapsing zone where the steady state concentration of pathogen remains significantly 
large when the system is hyper regulated. It’ll be safe if we stay in between 7 4* 10 10aDk
− −
−: and 
also 6 2* 10 10eDk − −−:  to avoid high pathogenic and effector T-cell population (see Figure 6).
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Figure 6:  Impact of vitamin-D over the steady state profiles of pathogen, [P] and effector T-cell, 
[TEff].
(a) We vary simultaneously the impact of [D*] over APCs  ( )*aDk and effector T-cells ( )*eDk . We 
find different regions: (i) At low vitamin-D impact ( )8 4* 10 10aDk − −−: we obtain pathogen defeated 
zone but  TEff flare-up zone ( )8 7* 10 10aDk − −−: .  (ii)  At  high vitamin-D impact ( )1 2* 10 10aDk − −:  
steady state concentration of pathogen largely increases which distinguished as pathogen relapsing 
zone. In pathogen relapsing zone, however we find TEff defeated zone. The basic value parameters 
are taken as 210, 10inp resek k= = . Other parameter values are taken from Table 1.
Discussion and Summary of Results
As  already  mentioned  recent  experiments  provided  quantitative  information  on  the 
immuomodulatory functions of vitamin-D and established functions of this vitamin beyond its 
well-stated role  in  calcium metabolism [19-25]. To understand these recent  experiments,  we 
developed  a  theoretical  coarse-grained  model  based  on  interaction  network.  The  network 
dynamically  connects  different  immune  components  that  are  experimentally  found  to  be 
involved in the vitamin-D regulated immune responses. The formulated kinetic scheme describes 
the time evolution of these components that mainly include pathogen, vitamin-D, APCs, effector 
T cells, regulatory T cells.  Here we summarize the pertinent observations that emerged from the 
kinetic network model.
(i) The steady state analysis of the present kinetic scheme finds the three regulation limits: weak, 
moderate  and  strong,  both  in  absence  and  presence  of  vitamin-D.  The  phase  diagrams  of 
boundary separated three immune regulation regions show that in presence of optimal vitamin-D, 
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strong regulatory region becomes broad and in the  moderate (or, bistable) regulatory region 
becomes more extended. The weak regulatory region shifts towards the large values of APC 
mediated effector T-cell activation rate (krese) and becomes more constricted than what happens 
in absence of vitamin-D. This investigation offers a semi-quantitative picture supporting several 
experimental and clinical observations that show how vitamin-D prevents the immune system 
from any sort  of  autoimmune  diseases  by  restricting  its  function  within  strong to  moderate 
regulation limits.  
(ii)    The  analysis  of  time  evolution  of  immunological  components  explicitly  shows  the 
attainment of a new steady state in the presence of optimal level of vitamin-D. The dynamical 
characterization  of  the  involved  components  reveals  that  the  recognition  of  the  pathogenic 
growth requires a few hours and this fact is in general agreement with most experimental results. 
After  the  activation  of  vitamin-D,  the  population  blast  of  effector  T-cells  relaxes  to  a 
comparatively lower value (as and when we include the effects of optimal vitamin-D). But such 
downward regulation for the prevention of autoimmune diseases costs re-entrant possibilities, to 
certain extent, of pathogen which again enhances the tolerance capability of a healthy immune 
system.  The  importance  of  vitamin-D  in  control  of  tolerance  has  also  been  experimentally 
verified.       
(iii)  Quantitative predictions  of the present model are in good agreement with several recent 
experimental  studies and clinical  observations  [12,  25,  42-48, 50-56].  We have  attempted to 
quantify how much vitamin-D is needed to resist autoimmunity and why. Our dose dependent 
variations  of  T-cell  responses  along  with  the  concentration  of  vitamin-D  seem  to  have  an 
excellent correlation with experimental findings of Jeffery et al. and Correale et al. [50, 25]. We 
additionally find that a safe range of vitamin-D is essentially determined by the interrelated level  
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of  pathogen,  effector  T-cells  and  regulatory  T-cells. The  range  is  restricted  by  both  hyper-
regulation and effector T-cell  inflammation.  Very recent randomized controlled trials  (RCTs) 
suggest that there should be an element of caution about recommending high serum 25(OH)D3 
concentrations as routine clinical practice and that should spread among the entire population. 
Thus both experimental and theoretical initiatives should begin to emerge by the above fact [54-
56]. 
(iv) The regulatory impact of active vitamin-D over APC and effector T-cells is investigated here 
by steady state analysis. We find that the nonlinear regulation of vitamin-D is sensitive towards 
APC functioning. This particular impact parameter largely controls the emergence and the range 
of bistability. Early experimental studies also report such markedly affected DC maturation and 
activation profile in presence of vitamin-D [21]. 
As  we mentioned  before,  the  steady state  analysis  of  the  proposed master  equations 
reveals  intricate  relations  between  vitamin-D  levels  and  T-regulatory  cells  maintained  by 
homeostasis. These relations suggest that at homeostasis, lower levels of [D in0] correspond to a 
lower population of T-regulatory cells, which again suggests that once a pathogen/antigen enters 
the body, the nature of the immune response is expected to be less regulatory and hence more 
inflammatory or aggressive. In addition in a weak regulation limit we have studied the temporal 
progression of both regulatory and effector T-cells.  Interestingly,  we find coupled oscillatory 
dynamics of effector T-cells (TEff) and regulatory T-cell (TReg) that begin to develop within 2-5 
days and periodically continue. In the presence of pathogen when the system tends towards a 
slightly  weak  regulation  regime  we  observe  a  dynamic  cross  regulation  in  the  temporal 
progression of regulatory and effector T-cells population. This is presented in the supplementary 
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material (see Figure S1). The impact of vitamin-D associated intrinsic oscillatory behavior over 
effector T-cells could provide a dramatic signature of disease phenotype in clinical therapy [29]. 
The critical role of the various cells involved in immune response, especially [Din0] and 
[D*] concentration could be understood via investigating dynamics of response. We are indeed 
aware of the fact that  quantitative results  of in-vivo analysis  of the effects  of the high dose 
vitamin D level or its any steroid analogue are somewhat ambiguous. The consequences of both 
low and very high dose of vitamin D causing fatal diseases are relatively well established. We 
are also aware of the persisting current dilemma of precisely defining the vitamin D insufficiency 
and difficulty in identifying the safe range. Our model calculation efficiently quantifies that there 
exist a delicate window of concentrations of vitamin-D which would be critical in maintaining an 
appropriate response to a pathogen. Extremely low levels of vitamin-D could lead to increased 
risk of autoimmune responses and extremely high levels would suggest an extremely tolerant 
response, which could increase the risk of tumors and cancerous cell growth and various allergic 
responses stimulated by the elevated IgE concentrations [55, 56]. 
It is important to note that two enzymes CYP27B1 and CYP24A1 and the population of VDR 
play important role in balancing several immunological responses.  Defect in or unavailability of 
any of these proteins will greatly perturb the whole immunological network. A series of D*-
VDR mediated processes that have enormous consequences have not been fully understood yet. 
Malfunction of these enzymes (such as:  CYP27B1 and CYP24A1) can also reflect  a deeper 
problem (such a genetic) that is difficult to rectify [57, 58]. It clearly needs a more quantitative 
analyses. 
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It  is  worth  mentioning  here  that  the  activation  of  a  naive  T  cell  into  an  effector  or 
regulatory T cell is also a complex process. This begins with the scanning of the surface of the 
APC's  in  the  lymph  nodes  for  the  MHC class  II  type  molecules  by the  naive  T cells.  If  a 
particular epitope is recognized and co-stimulatory molecules are present,  then the activation 
process is initiated [59, 60]. Now this can be understood via an energy landscape analysis. The 
process of successful activation can be thought of as the T cell negotiating a barrier in the energy 
landscape. This can be brought about through either a single successful contact with an APC or 
multiple contacts if the second or later contact occurs within a finite time. If the T-cell is above 
the seperatrix in the energy landscape then the probability of a successful activation is higher 
which is only present for a finite time after the previous excitation. The above picture is similar 
to the immunological studies carried out by Hong et al. [61] and Das et al. [60] and the enzyme 
catalysis model proposed by Min, Xie and Bagchi earlier [62]. However, to make the present 
model tractable, we had to ignore such complexity of T-cell activation. 
The  master  equation  approach  adopted  here  can  be  and  has  been  solved  both  by  a 
deterministic and a stochastic approach, given the initial values of the parameters and the fluxes. 
Within a biological cell, there can always be large fluctuations due to environmental factors or 
other causes [63, 64]. Such fluctuations can induce the cross-over from weak regulation to strong 
regulation. This is an issue that deserves further study.
Although our model is coarse-grained and the evaluated results are semi-quantitative due 
to  absence  of  some  kinetic  parameters,  this  study,  perhaps,  constitutes  the  first  theoretical 
investigation of the role of vitamin-D in immune regulation. Despite its limitations, we believe 
that the kinetic interplay between pathogen, effector T-cells and the unavoidable participation of 
vitamin-D to remain the basic ingredients in the upcoming studies.     
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In future, we plan to extend our system of equations to include effects of drugs such as 
immune suppressants such as glucocorticoids that introduce a further competition in the reaction 
network [13]. The role of immune suppressants is not fully understood but known to exhibit 
serious side effects like cancer.
Methods
 Coarse-grained reaction network model development
As already mentioned, in order to describe the complex interplay among different types 
of immune cells, pathogens and the modulatory role of vitamin-D, we need to develop in the 
beginning  a  simple  coarse-grained  approach  that  can  both  be  solved  and  understood.  The 
complexity arises because of the large number of biochemical machineries in the human body 
that are strongly coupled with each other [65, 66].  Understanding the relationship between these 
different machineries involving different types of cell  may ultimately require detailing at  the 
molecular level. A simpler, albeit cruder version is proposed here that accounts for some of the 
complexities  present  at  the molecular  levels  by coarse-graining them at the cellular  level.  A 
pictorial description of initial complex network and the associated coarse-grained network are 
demonstrated in the supplementary material (see Figure S2 and S3). With this goal in mind, we 
perform model analysis based on T-cell activation, deactivation and regulation, following some 
experimental results discussed below. 
(i) Myeloid dendritic cells (here we call them as antigen presenting cell (APC)) which 
are present in different organs are the key players involved in triggering the onset of 
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an adaptive response. While pathogen phagocytosed dendritic cells serve to activate 
naive T cells into effector T cells, immature dendritic cells upon pathogen contact 
convert naive T cells into regulatory T cells [19, 20].
(ii)  Effector  T-cells  (described  in  the  supplementary  material,  S1)  release  cytokines 
which upregulate the activity of 1α-hydroxylase enzyme (CYP27B1), which in turn 
increases  production  of  active  vitamin-D [D*] from its  inactive  form. It  is  worth 
mentioning here the extensive experimental study by Correale et al. which reported 
that  CD4+ T cells are capable of metabolizing 25(OH) Vitamin D to 1,25 (OH)2 
Vitamin D, which again inhibits T cell function [25].
(iii)     Active form of vitamin-D, 1, 25(OH)2D3  modulates the immune response through 
the inhibition of DC differentiation and maturation into potent APC [21].
(iv)    While effector T cells are directly inhibited by the increased production of [D*], 
CD4+CD25+  FoxP3+  regulatory  T  cells  (TReg)  cells  become  up-regulated.   In 
addition, these TReg cells also efficiently inhibit T-effector cells proliferation [22-24]. 
However,  previous  experimental  data  confirms  that  IL-10  is  a  positive  autocrine 
factor. They act directly on effector T cells even in the absence of antigen presenting 
cells, enhancing the regulatory action of 1,25 (OH)2Vitamin D [25].
Coarse-graining  of  the  interaction  network  is  accomplished  through  making  a  few 
simplifying observations and vital assumptions. They are as follows:
 (a)  Th1, Th2 and Th17 cells are grouped together as effector T-cells. The detailed description of 
these T-cells is depicted in the supplementary material (S1) [16].
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(b) It is well established that the primary molecular action of 1,25(OH)2D3 is to initiate gene 
transcription by binding to VDR which is a member of the steroid hormone receptor superfamily 
of ligand-activated transcription factors. VDR therefore is an important factor in 1,25(OH)2 D3 
mediated functions. More detailed information about the molecular activation of VDR and its 
role in gene transcription can be obtained from the recent review appraised by Pike et al. [67].
On contrary, we found that there are growing evidences that 1,25(OH)2D3 also has rapid 
actions that are not essentially mediated through transcriptional events involving VDR. They are 
in fact membrane initiated actions [68].  In the present model we have not included the effect of 
VDR. We have only considered the production of active vitamin-D from its inactive form upon 
T-cell activation. 
   (c) In circulation, the inactive form of vitamin-D, 25(OH)D3, is generally used as an indication 
of vitamin-D status. However, in dendritic cells (DC) use of this precursor depends on its uptake 
by cells and subsequent conversion by the enzyme CYP27B1 into active 1,25(OH)2D3 [69].  It is 
represented as [D*]. Active Vitamin-D, [D*], has a tight control over the homeostatic production 
rate  that  auto-regulates  its  production  by  directly  upregulating  the  activity  of  the  P450 
cytochrome CY24A1. In our model we have considered the steady state rate of inactive vitamin-
D that found from experimental and clinical measurements while keeping the concentration of 
these enzymes as the implicit factors.
In the present context we consider the following set of biological transformations. Most of them 
are catalytic reaction in terms of up-regulation or down-regulation. 
(1) The primary step is the annihilation of pathogen by effector T-cell.
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( ) ( )Eff killed EffPathogen P +Effector T-cell T P + T→                           (i)   
 (2) Production of effector T-cell requires the presence of active antigen presenting cell 
(APC). Active APC, on the other hand is produced by following sequence of reactions. 1st 
resting APC forms through the interaction between inactive APC and pathogen. 
  
( ) ( )in ResInactive APC A +P Resting APC A +P→                                            (ii)
(3) Further pathogenic contact and/or effector T-cell contact promotes the resting APC to 
turn out to be active APC.
Res Act
Res Eff Act Eff
A +P A +P     
A +T A + T
→  
→ 
                                                                               (iii)       
(4) Then effector T-cell is produced by the interaction between precursor/native T-cell 
with active APC.
( ) ( )Nat EffAct ActNative T-cell T +Active APC A T + A→                         (iv)       
(5) Simultaneously inactive vitamin-D is transformed into active vitamin-D upon effector 
T-cell contact.
( ) ( )in Eff EffInactive Vitamin-D +T ActiveVitamin-  D*D +TD →                (v)
(6) Resting T-cells and Vitamin-D, both can initiate the formation of regulatory T-cell 
from native T-cell. 
( ) ( )Nat Res Reg ResNative T-cell T +Resting APC A T + A→                   (vi)    
( ) ( ) RNa et gNative T-cell T +Activ D*e Viatmin-D T +D*→
(7) Both Regulatory T-cell and active vitamin-D annihilate effector T-cell to control the 
hyperactivity of the immune system. 
killed
Eff Eff
kill
Reg Reg
ed
Eff Eff
+T T      T T +
T T +D+D **
→
→
   
                                                            (vii)
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(8) The cycle is completed by the transformation of active APC to resting again by the 
same duo, TReg and D* which work at tandem.
Act Reg Res Reg
Act Res
A +T A T     +
+D
 
A +D* A *
 →
→
  
                                                                (viii) 
Master equations quantifying the reaction network dynamics
Now,  some  important  further  assumptions  before  we  set  about  writing  the  master 
equations:
(i) For Pathogen/Antigen, inactive APC and native T-cells, each has a birth rate which includes 
influx and proliferation rates and a death rate similar to decay which incorporates natural cell 
death. The death rate of each component is linear with its concentration.
(ii)  The transition probabilities  are all  assumed to be constant  with time but may vary from 
system to system (i.e. here person to person) according to the condition applied. 
(iii) To scale the unit, here we assume that in absence of pathogen, hundred (average number of 
T-cell present in hundred nano-liter blood sample) precursor T-cells pre-exist.  
The above annihilation, recombination and catalytic reactions lead to the following set of 
coupled master equations. The equations are size-extensive. In fact the size extensibility is the 
critical robustness of our model. 
P P P Eff
dP P k T P
dt
σ pi= − −                                                                                 (1)
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in
A inp in a in
dA
k A P m A
dt
σ= − −                                                                            (2)
Reg * *Res inp in ar Act aD Act rese Res Eff inp Res a Res
dA
k A P k T A k A D k A T k A P m A
dt
= + + − − −  (3)
Reg * *
Act
rese Res Eff inp Res ar Act aD Act a Act
dA
k A T k A P k T A k A D m A
dt
= + − − −          (4)
* *Nat T an Act Nat resn Res Nat nD Nat n Nat
dT k A T k A T k T D m T
dt
σ= − − − −             (5)
Reg * *
Eff
an Act Nat er Eff eD Eff e Eff
dT
k A T k T T k T D m T
dt
= − − −                            (6)
Reg
* Reg*resn Res Nat nD Nat r
dT
k A T k T D m T
dt
= + −                                                  (7)
in
D eD Eff in D in
dD
k T D m D
dt
σ= − −                                                                   (8)
*
* *eD Eff in D
dD k T D m D
dt
= −                                                                              (9)
Where the terms signify as follows:
 kij → Transition probability rates, 
Kσ → Production rate by body of component k , 
 im  → Overall death rate of component i ,
 P → Concentration of Pathogen/Antigen/Self-Antigen etc,
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inA → Concentration of inactive antigen presenting cells without pathogen capture, 
ResA → Concentration of resting antigen presenting cells after pathogen capture,
ActA → Concentration of activated antigen presenting cells after pathogen recognition and 
effector T-cell contact.  
  NatT  → Concentration of naive antigen-specific T cells,
EffT → Concentration of effector T cells,
RegT → Concentration of regulatory T cells,
inD → Concentration of Inactive form of Vitamin-D3 (1, 25(OH)D) in the body 
*D → Concentration of active form of Vitamin-D3 (1, 25(OH)2D) in the body 
That  is,  we have used the same letter  to denote both the species and its  concentration.  This  
should not cause any confusion.
   System parameters and data analysis
A set of nine coupled differential equations is difficult to solve analytically. We obtain 
the time dependent concentrations of all the components involved in the scheme by employing 
the  well-known  stochastic  simulation  analysis  proposed  by  Gillespie  [38].  Both  the  single 
molecular as well as ensemble enzyme catalysis have been studied following this method. All the 
results presented in this article are derived using stochastic simulation method. However, we 
have also verified the consistency of each result by using the deterministic approach which is 
easier to implement.
34
           Here we have considered one hundred nano-litre volume of blood sample. In the absence 
of  pathogen  this  blood  sample  effectively  contains  the  steady  state  concentration  of  all  the 
precursor cells. [70-72] Since all the reactions are bimolecular, the volume dependence of the 
reaction is expected to be an issue.  Thus, we have kept fixed the box volume to one hundred 
nano-liter and all the rate constants are in the unit of per day. We have closely followed the type 
of formalism developed in Ref. 30.
 Furthermore, we have assumed that in the absence of antigen, hundred precursor T-cells 
can  pre-exist  within  this  fixed  volume (100 nano-litre),  in  accord  with  known experimental 
values [70, 71]. These T-cells have a 1% turnover per day. Concentrations of pathogens and 
APCs  are  also  normalized.  The  production  rate  and  death  rate  of  these  components  are  so 
assigned that their steady state values become one. Other associated probabilities/rate constants 
of different reaction sets are used from early papers in this field [30]. However, for vitamin D, 
the production and mortality rate constants are calculated from their steady state concentration. 
Other  vitamin  D related  rate  constants  are  treated  as  variable  in  our  study,  as  we have  no 
experimental  data available  on them. In reality,  such model  requires to  estimate several  rate 
parameters values. Accurate values of some of these rate constants are unfortunately very hard to 
determine. Such rate parameters depend on several factors and differ from species to species. So 
they do not have any specific  standard value.  As for example,  it  would be quite difficult  to 
determine the mortality rate of effector and regulatory T-cell as in the present model these rate 
parameters  also  include  the  proliferation  rate  along  with  their  death  rate.  Moreover  the 
pathogenic stimulation could be at various ranges according to their strength and pattern. 
Hence the primary difficulty of predictive theoretical research in this area is the absence 
of  accurate  values  of  rate  constants/transition  probabilities.  In  the  present  study  we  have 
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employed the following approach to circumvent this difficulty.  (i) In some cases where values 
could be estimated from literature, we have used the known value and varied it over a range to 
check the sensitivity of results. (ii) In a few cases, order of magnitude estimates for values were 
employed.  [30]  We also focused on exploring  the  phase diagram by varying some key rate 
parameters that are not known and looked for the optimum region where results are sensitive to 
the  parameter  space  (given  experimental  and  assumed  values  of  the  rate  constants  and 
concentrations). To this end, we have varied the rate constants over a significantly wide range. 
In addition, the concentration of precursor elements was normalized, so as to reflect manifold 
change in the production level. Taking typical values as mentioned below (see Table 1), the time 
evaluation of the system and other analyses are performed in the present work. Here we have 
used the standard definition of steady state, i.e.; when the concentration of different species is 
invariant with time (dc/dt=0). In particular, for stochastic simulation, a steady state is assumed to 
reach when the concentration of a species fluctuates around a mean value without any noticeable 
drift at long time.
Table 1: Basic parameter values (*time duration is taken as “days”).
Parameter Symbol Value
Reproduction rate of pathogen
Pσ
1
Death rate of pathogen
Ppi
1
Birth rate of APC
Aσ
0.2
Death rate of APC
am 0.2
Rate of pathogen killing by 
efffector-T cells Pk
100
Rate of APC activation by 
pathogen inpk
Variable
Rate of APC reactivation by 
effector T cells resek
Variable
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Rate of APC inhibition by 
regulatory T cells ark
10-1
Rate of APC inhibition by 
active vitamin-D *aDk
Variable
Birth rate of Native T cells
Tσ
1
Rate of differentiation of 
native T cell to effector T cell 
induced by active APC
ank
1
Rate of differentiation of 
native T cell to regulatory T 
cell induced by resting APC
resnk
1
Mortality rate of native T cell 
nm 0.01
Rate of inhibition of effector T 
cell by active vitamin-D *eDk
Variable
Rate of inhibition of effector T 
cell by regulatory T cell erk
10
Rate of decay of effector T 
cells em
0.1
Rate of regulatory T cell 
reactivation by active vitamin-
D
*nDk
10-7
Rate of decay of regulatory T 
cells rm
0.1
Production rate of inactive 
vitamin-D Dσ
1
Death rate of inactive vitamin-
D Dm
10-9
Rate of reactivation of active 
vitamin-D induced by effector 
T cells
eDk 10
-7
Rate of deactivation of active 
vitamin-D *Dm
10-2
Acknowledgments
It is a pleasure to thank Prof. Anjali A. Karande, Dr. Mantu Santra, Dr. Biman Jana, Ms. Gauri 
Ranadive, Mr. Manoj Kumar Mahala and Mr. Kushal Bagchi for many helpful discussions. This 
work was supported in parts by grants from DST (India) and Sir J.C. Bose Fellowship (DST).
37
Authors Contribution
S.R. and B.B. designed research; S.R. and K.S. performed research; S.R. and B.B. analyzed data; 
and S.R. and B.B wrote the article. 
Conflict of Interest
Authors don’t have a conflict of interest.
References
1. Autier P, Gandini S (2007) Vitamin D supplementation and total mortality: A metaanalysis 
of randomized controlled trials. Arch Intern Med 167: 1730–7.
2. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357: 266–281.
3. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK et al. (2011) The 2011 
report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: 
what clinicians need to know. J Clin Endocrinol Metab  96:53–58.
4. Hewison M (2011) Vitamin D and innate and adaptive immunity. Vitam Horm  86: 24-62.
5. Cutolo M, Plebani M, Shoenfeld Y, Adorini L, Tincani A. (2011) Vitamin D endocrine 
system and the immune response in rheumatic diseases. Vitam Horm 86:327–51.
6. Hewison M (2012) An update on vitamin D and human immunity. Clinical Endocrinology 
76, 315–325.
7. Williams CJB (1849) On the use and administration of cod-liver oil in pulmonary 
consumption. London Journal of Medicine 1:1–18.
8. Finsen, NR (1903) Nobel Prize presentation speech by professor the count K.A.H. Morner, 
Rector of the Royal Caroline Institute on December 10, 1903.
9. Moller KI, Kongshoj B, Philipsen PA, Thomsen VO, Wulf  HC (2005) How Finsen's light 
cured lupus vulgaris. Photodermatol Photoimmunol Photomed  21:118-124.
38
10. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J et al. (2004) Cutting edge: 1, 
25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J 
Immunol  173: 2909-2912.
11. Kamen DL, Tangpricha V (2010) Vitamin D and molecular actions on the immune system: 
Modulation of innate and autoimmunity. J Mol Med (Berl) 88: 441–450.
12. Bikle D (2009) Nonclassic actions of vitamin D. The Journal of Clinical Endocrinology & 
Metabolism 94:26-34.
13. Dimeloe S, Nanzer A , Ryanna, K, Hawrylowicz C (2010) Regulatory T cells, inflammation 
and the allergic response-The role of glucocorticoids and vitamin D. J Ster Biochem Mol Bio 
120:86–95.
14. Kamen D, Aranow C (2008) Vitamin D in systemic lupus erythematosus. Curr Opin 
Rheumatol 20:532–537.
15. Adorini L (2003) Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance 
regulatory T Cells inhibiting autoimmune diabetes. Ann  N Y Acad Sci 987: 258-261.
16. Supplementary  material  of  “A  stochastic  chemical  dynamic  approach  to  correlate 
autoimmunity and optimal vitamin-D range”. It includes the description of effector T-cells 
and  their  role  in  immune  system.  We  additionally  demonstrated  the  time-dependent 
oscillatory  behavior  of antigen-specific  effector  (TEff)  and regulatory (TReg)  T cells  and a 
pictorial description of complex and coarse-grained network formalism.
17. Jonuleit H, Schmitt E, Steinbrink K, Enk AH (2001)  Dendritic cells as a tool to induce 
anergic and regulatory T cells. Trends Immunol 22: 394–400.
18. Lutz MB, Schuler G (2002) Immature, semi-mature and fully mature dendritic cells: which 
signals induce tolerance or immunity? Trends Immunol 23:445–449.
19. Jonuleit  H, Schmitt  E,  Schuler,  G, Knop J,  Enk AH (2000) Induction of Interleukin 10–
producing, nonproliferating CD4+ T Cells with regulatory properties by repetitive stimulation 
with allogeneic immature human dendritic cells. J Exp Med 192: 1213–1222.
20. Powrie F, Maloy KJ (2003) Regulating the regulators. Science 299: 1030–1031.
21. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Cin ED et al. (2000) Vitamin D3 
affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J 
Immunol 164:4443-4451.
39
22. Penna G, Roncari A, Amuchastegui S, Daniel KC, Berti E, Colonna M et al. (2005) 
Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of 
CD4+Foxp3+ regulatory T cells by 1, 25-dihydroxyvitamin D3. Blood 106:3490–3497.
23. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L (2001) 
Regulatory T cells induced by 1 alpha, 25-dihydroxyvitamin D3 and mycophenolate mofetil 
treatment mediate transplantation tolerance. J Immunol 167:1945-1953.
24. Schuster I, Egger H, Herzig G, Reddy GS, Schmid JA, Schüssler M et al. (2006) Selective 
inhibitors of vitamin D metabolism -New concepts and perspectives.  Anticancer Research 
26:2653-2668.
25. Correale J, Ysrraelit MC, Gaitán MI (2009) Immunomodulatory effects of Vitamin D in          
multiple sclerosis. Brain 132:1146–1160.
26.   Peelen E, Knippenberg S, Muris AH, Thewissen M, Smolders J, Tervaert JWC, Hupperts R, 
Damoiseaux J (2011) Effects of vitamin D on the peripheral adaptive immune system: A 
review. Autoimmunity Reviews 10: 733–743.
27. Lo WC, Arsenescu RI, Friedman A (2013) Mathematical model of the roles of T cells in 
inflammatory bowel disease.  Bull Math Biol 75:1417-33.
28. Pillis LD, Caldwell T, Sarapata E, Williams H (2013) Mathematical modeling of regulatory 
T cell effects on renal cell carcinoma treatment. Discrete and continuous dynamical systems 
series B 18:915-943.
29.  Martinez-Pasamar S, Abad E, Moreno B, Mendizabal NVD, Martinez-Forero I, Garcia-
Ojalvo J et al. (2013) Dynamic cross-regulation of antigen-specific effector and regulatory T 
cell subpopulations and microglia in brain autoimmunity. BMC Systems Biology 7:34.
30. Fouchet D, Regoes R. A (2008) Population dynamics analysis of the interaction between 
adaptive regulatory T Cells and antigen presenting cells. Plos One 3: e2306.
31. Hopfield JJ (1974) Kinetic Proofreading: A New Mechanism for reducing errors in 
biosynthetic processes requiring high specificity. Proc Nat Acad Sci USA 71: 4135.
32. Qian H (2003) Thermodynamic and kinetic analysis of sensitivity amplification in biological 
signal transduction. Biophys Chem 105:585-93.
33. Chaudhury S, Cao J, Sinitsyn NA (2013) Universality of Poisson indicator and Fano factor of 
transport event statistics in ion channels and enzyme kinetics. J Phys Chem B 117:503–509.
34. Wu Z, Xing J (2012) Functional roles of slow enzyme conformational changes in network 
dynamics. Biophys J 103:1052-1059.
40
35. Min W, Xie XS, Bagchi B (2008) Two dimensional reaction free energy surfaces of catalytic 
reaction: Effects of protein conformational dynamics on enzyme catalysis. J Phys Chem 
112:454-466.
36. Santra M, Bagchi B (2012) Catalysis of tRNA-Aminoacylation: Single turnover to steady 
state kinetics of tRNA synthetases. J Phys Chem B 116:11809-11817.
37. Santra M, Bagchi B (2013) Kinetic proofreading at single molecular level: Aminoacylation 
of tRNAIle and the role of water as an editor. Plos One  8: e66112. 
38. Gillespie DT (1976) A general method for numerically simulating the stochastic time 
evolution of coupled chemical reactions. J Comput Phys 22: 403–434.
39. Turner TE, Schnell S, Burrage K. (2004) Stochastic approaches for modelling in vivo 
reactions. Comput Biol Chem. 28:165-78.
40. Wilhelm T (2009) The smallest chemical reaction system with bistability.  BMC Systems 
Biology 3: 90.
41. Ghosh S, Banerjee S,  Bose I (2012) Emergent bistability: Effects of additive and 
multiplicative noise. Eur. Phys. J. E 11:1-14, 
42. Whitmire JK, Eam B, Whitton JL (2008) Tentative T cells: memory cells are quick to 
respond, but slow to divide. PLoS Pathog. 4:e1000041. 
43. von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C (2010) Vitamin D 
controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 11: 
344–9.
44. Cutolo M, Pizzorni C, Sulli A (2011) Vitamin D endocrine system involvement in 
autoimmune rheumatic diseases. Autoimmunity Reviews 11: 84–87.
45. Opferman JT, Ober BT, Ashton-Rickardt PG (1999) Linear differentiation of cytotoxic 
effectors into memory T lymphocytes. Science 283:1745-1748.
46. Adorini L (2005) Intervention in autoimmunity: The potential of vitamin D receptor agonists. 
Cellular Immunology 233:115–124.
47. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L (2001) 
Regulatory T cells induced by 1 alpha, 25-dihydroxyvitamin D3 and mycophenolate mofetil 
treatment mediate transplantation tolerance. J Immunol 167:1945-1953.
48. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic selftolerance 
maintained by activated T cells expressing IL-2 receptor a-chains (CD25). Breakdown of a 
41
single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 
1151–1164.
49. Leon K, Perez R, Lage A, Carneiro J (2000) Modelling T-cell-mediated suppression 
dependent on interactions in multicellular conjugates. J Theor Biol 207: 231–254.
50. Jeffery LE, Wood AM, Qureshi OS, Hou TZ, Gardner D, Briggs Z et al. (2012) Availability 
of 25-Hydroxyvitamin D3 to APCs controls the balance between regulatory and 
inflammatory T Cell responses. J Immunol 189:5155-5164.
51. Harris SS (2005) Vitamin D in type 1 diabetes prevention. J Nutr  135:323-325.
52. Ross AC, Taylor CL, Yaktine AL, Valle HBD (2011) Dietary reference intakes for calcium 
and vitamin D. Washington, D.C: National Academies Press. 435.
53. Moyad, MA (2009) Vitamin D: A Rapid Review. Dermatology Nursing 21(1): 1-11. 
54. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ et al. (2010) 
Circulating 25-Hydroxyvitamin D and risk of pancreatic cancer. Am J Epidemiol 172: 81–93.
55. Sanders KM, Nicholson GC, Ebeling PR. (2013) Is high dose vitamin D harmful? Calcif 
Tissue Int 92:191–206.
56. Hypponen E, Berry DJ, Wjst M, Power C (2009) Serum 25-hydroxyvitamin D and IgE – a 
significant but nonlinear relationship. Allergy 64: 613–620.
57. Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, Kato S (1997) 25-
Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 277:1827–30.
58. Jones G, Prosser DE, Kaufmann M (2012) 25-Hydroxyvitamin D-24-hydroxylase 
(CYP24A1): Its important role in the degradation of vitamin D. Arch Biochem Biophys 
523:9-18.
59. Lutz MB, Schuler G (2002) Immature, semi-mature and fully mature dendritic cells: which 
signals induce tolerance or immunity? Trends in Immunology 23:445–449.
60. Das J, Ho M, Zikherman J, Govern C, Yang M, Weiss A et al. (2009) Digital signaling and 
hysteresis characterize Ras activation in lymphoid cells. Cell 136: 337-351.
61. Hong T, Xing J, Li L, Tyson JJ (2012) A simple theoretical framework for understanding 
heterogeneous differentiation of CD4+ T cells. BMC Systems Biology 6:66.
42
62. Min W, Xie XS, Bagchi B (2009) Role of conformational dynamics in kinetics of an 
enzymatic cycle in a nonequilibrium steady state. J Chem Phys 131:065104.
63. Qian H, Shi PZ, Xing J (2009) Stochastic bifurcation, slow fluctuations, and bistability as an 
origin of biochemical complexity. Phys Chem Chem Phys 11:4861–4870.
64. Sasmal D, Ghosh S, Das A, Bhattacharyya K (2013) Solvation dynamics of biological water 
in a single live cell under a confocal microscope. Langmuir 29: 2289-2298.
65.  Mandlik V, Shinde s, Chaudhary A, Singh, S (2012) Biological network modelling identifies 
IPCS in Leishmania as a therapeutic target. Integr Biol 4:1130-1142.
66. Jerne NK (1974) Towards a network theory of the immune system.  Ann Immunol (Paris) 
125C:373-89.
67. Pike JW, Meyer MB, Bishop KA (2012) Regulation of target gene expression by the vitamin 
D receptor - an update on mechanisms. Rev Endocr Metab Disord 13:45–55.
68. (a) Fleet JC (2004) Rapid, membrane-initiated actions of 1, 25 dihydroxyvitamin D: What 
are they and what do they mean? J Nutr 134:3215–3218. (b) Fleet JC (2008) Molecular 
actions of vitamin D contributing to cancer prevention. Mol Aspects Med 29: 388–396.
69. Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J et al. (2004) Relation of 
CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic 
status and expression of allergic disease. Lancet 363: 608–615.
70. Ligthart, GJ, Schuit, HR, Hijmans, W (1985) Subpopulations of mononuclear cells in ageing: 
expansion of the null cell compartment and decrease in the number of T and B cells in human 
blood. Immunology 55: 15–21.
71. Bates MF, Khander A, Steigman SA, Tracy TF Jr, Luks FI. (2014) Use of white blood cell 
count and negative appendectomy rate. Pediatrics 133:e39-44.
72. Fearnley DB, Whyte LF, Carnoutsos SA, Cook AH, Hart DN (1999) Monitoring human 
blood dendritic cell numbers in normal individuals and in stem cell transplantation. Blood 
93:728-36.
43
